Stock listing
Fortress Biotech, Inc.
Selected listing: FBIO · NASDAQ · USD · US
Fortress Biotech, Inc. (NASDAQ:FBIO), Health Technology. Latest release Sep 8, 2026: Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global…
- Ticker
- NASDAQ:FBIO
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Fortress Biotech, Inc.
The company focuses on developing and commercializing innovative pharmaceutical and biotechnology products. Fortress Biotech aims to advance its portfolio through strategic partnerships and collaborations within the healthcare sector.
Latest news from Fortress Biotech, Inc.
Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 8, 2026
Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
August 13, 2026
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics $130 Million Series B Financing
July 28, 2026
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing
July 27, 2026
Fortress Biotech to Participate in A.G.P.’s Annual Virtual Healthcare Conference
May 18, 2026
Events
Research Fortress Biotech, Inc.
Fortress Biotech, Inc. company profile
View the public company page for Fortress Biotech, Inc. on 6ix.
Fortress Biotech, Inc. news
Read company news and market updates connected to Fortress Biotech, Inc..
Fortress Biotech, Inc. investor events
Find investor webinars, events, and replay context for Fortress Biotech, Inc..
Alternate listings
FBIOP:NASDAQ
US · USD
Alternate listing for Fortress Biotech, Inc.; the primary context on this page is FBIO:NASDAQ.
FBIOP:BOATS
US · USD
Alternate listing for Fortress Biotech, Inc.; the primary context on this page is FBIO:NASDAQ.
FBIO:BOATS
US · USD
Alternate listing for Fortress Biotech, Inc.; the primary context on this page is FBIO:NASDAQ.